TEL AVIV, Israel, May 2, 2024 /PRNewswire/ --  AISAP, whose AI-powered Point Of Care Assisted Diagnosis (POCAD)™ solution is transforming the medical ultrasound industry, announced its seed funding round today. The company secured $13 million, led by Harel Insurance Investments & Financial Services Ltd. and Shoni Top Ventures, L.P.
Ultrasound scans are crucial for discovering and diagnosing many medical conditions. However, it can often take weeks or months to receive a diagnosis, primarily due to a chronic lack of qualified medical professionals, as well as the logistical difficulties of transporting patients to the scan. As a result, many patients get left behind. While portable POCUS devices do exist – removing the need to transport patients to and from scans – these devices don't solve the fundamental problem, as they, too, can only be operated by experts
While portable POCUS devices do exist – removing the need to transport patients to and from scans – these devices don't solve the fundamental problem, as they, too, can only be operated by experts
AISAP's POCAD™ solution solves this challenge by providing AI-powered diagnoses that are both highly accurate and easy for any physician to understand – not just ultrasound experts. This includes a unique "urgency score" that enables medical providers to prioritize cases based on the severity of the condition; a score that measures the quality of the scan for operators, to ensure accuracy even if they are less familiar with traditional ultrasound devices; and Deep Learning AI capabilities that enable accurate readings even with lower-quality images from handheld machines. Unlike most other POCUS devices, AISAP's POCAD™ solution can even provide detailed, accurate diagnoses of specific valves within the cardiovascular systems. And while the average ultrasound takes weeks on average to provide a full analysis and diagnosis, AISAP's solution does so in as little as 5 minutes
And while the average ultrasound takes weeks on average to provide a full analysis and diagnosis, AISAP's solution does so in as little as 5 minutes
AISAP's algorithms have been trained on more than 300,000 studies comprising over 24 million video clips, and the technology has been validated by a range of medical experts from The Mayo Clinic, Inova Health Foundation, Jefferson Health, Poriya Institute and more.
In a recent study – still currently under review at Israel's Sheba Medical Center – 660 patients who had not received a full ultrasound underwent AISAP scans at the Emergency Department or Internal Medicine units. In 29% of those cases, the AISAP solution discovered at least one previously-unknown, moderate medical condition.
AISAP was founded by a unique group of experts from the medical, technology and intelligence worlds, united in their vision for universally accessible medical care. Its co-founders are Adiel Am-Shalom – who managed R&D and Cyber teams in the Israel Defense Force's elite 8200 intelligence unit and the founder of IDL; Ehud Raanani – Director of the Leviev Cardiovascular and Thoracic Center at Israel's Sheba Medical Center; Robert Klempfner – Director of the Israeli Center for Cardiovascular Research; and Ehud Schwammenthal – a world-renowned expert in echocardiography and the founder of both Ventor Technologies and Magenta Medical. While AISAP's POCAD™ solution is currently focused on the area of cardiac medicine, the company is developing additional products in other anatomical areas as well
While AISAP's POCAD™ solution is currently focused on the area of cardiac medicine, the company is developing additional products in other anatomical areas as well

Source prnewswire